Owkin

Owkin

Biotechnology, 831 Broadway, New York, 10003, United States, 201-500 Employees

owkin.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 16*********

Who is OWKIN

Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions ...

Read More

map
  • 831 Broadway, New York, New York, 10003, United States Headquarters: 831 Broadway, New York, New York, 10003, United States
  • 2016 Date Founded: 2016
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7373 | NAICS Code: 541512 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from OWKIN

Owkin Org Chart and Mapping

Employees

Anna Huyghues-Despointes

Chief Corporate Development and Strategy Officer

Talia Lliteras

Marketing Director Diagnostics

Benning Wang

Principal Partnerships Manager, North America

Charles Maussion

Director of Biomarkers R&D

Maedbh Heaney

Partnerships Manager, Us & Canada

Dinesh Divakaran

Vice President of Partnerships, North America

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Owkin

Answer: Owkin's headquarters are located at 831 Broadway, New York, 10003, United States

Answer: Owkin's phone number is 16*********

Answer: Owkin's official website is https://owkin.com

Answer: Owkin's revenue is $50 Million to $100 Million

Answer: Owkin's SIC: 7373

Answer: Owkin's NAICS: 541512

Answer: Owkin has 201-500 employees

Answer: Owkin is in Biotechnology

Answer: Owkin contact info: Phone number: 16********* Website: https://owkin.com

Answer: Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner. We use AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools. Using federated learning, a pioneering collaborative AI framework, Owkin enables partners to unlock valuable insights from siloed datasets while protecting patient privacy and securing proprietary data. Owkin was co-founded by Thomas Clozel MD, a former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016. Owkin has raised over $300 million and became a unicorn through investments from leading biopharma companies (Sanofi and BMS) and venture funds (Fidelity, GV and BPI, among others).

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access